B. Jefferson Clark

CIK 1435388 · last filed 2015-01-12

B. Jefferson Clark is a corporate insider who has filed 5 SEC Form 4 insider transactions across 2 companies since 2013. Across all open-market trades the lifetime net is +$1.4M, making them a net buyer over the disclosed history. 13 SEC filings were submitted jointly with Aldagen Holdings, LLC.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$0

Companies

2

Total Filings

5

Lifetime Open-Market Net

$1.44M

Filer Profile

Reported Address

C/O ALDAGEN, INC., 2810 MERDIAN PARKWAY
SUITE 148
DURHAM, NC 27713

Related Filers

Aldagen Holdings, LLC — 13 joint filings, latest 2015-05-13

William W Brooke — 13 joint filings, latest 2015-05-13

Kathryne Carr — 5 joint filings, latest 2015-03-12

Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
Tobira Therapeutics, Inc. (TBRA) Delisted	Director	—	—	—	$0	1	2015-01-05
Tobira Therapeutics, Inc. (RGDO) Delisted	Director	125,570	—	—	$1.44M	3	2014-03-03

Recent Filings

5 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2015-01-12	—	Sell (S)	−652,149	-$228.3K
2015-01-05	Tobira Therapeutics, Inc. (TBRA) Delisted	Grant (A)	—	$0	EDGAR
2014-03-03	Tobira Therapeutics, Inc. (RGDO) Delisted	Exer (X)	+15,374	$47.4K	EDGAR
2014-01-03	Tobira Therapeutics, Inc. (RGDO) Delisted	Grant (A)	—	$0	EDGAR
2013-08-29	Tobira Therapeutics, Inc. (RGDO) Delisted	Mixed	+1,095,448	$1.44M	EDGAR

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.